Enalapril formulations | Patent Publication Number 20210251956

US 20210251956 A1

Patent NumberUS 11141405 B2

Application Number17228024

Filled DateApr 12, 2021

Priority DateMar 18, 2016

Publication DateAug 19, 2021

Original AssigneeAzurity Pharmaceuticals Inc.

Current AssigneeJpmorgan Chase Bank

Inventor/ApplicantsGerold L. Mosher
David W. Miles

Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.

Check our Latest Report Purchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.